Autologous Hematopoietic Progenitor Cell Transplant
Sponsors
H. Lee Moffitt Cancer Center and Research Institute, Memorial Sloan Kettering Cancer Center
Conditions
AmyloidosisMultiple MyelomaNeoplasms, Nerve TissueNeuroblastoma
Phase 1
A Combined Cell Therapy Approach to the Treatment of Neuroblastoma
WithdrawnNCT02745756
Start: 2016-04-14End: 2017-08-21Updated: 2017-08-30
Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.
Active, not recruitingNCT02909036
Start: 2016-09-30End: 2026-09-30Updated: 2025-10-10